CEOcast
Broadcasting · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
369 Lexington Ave, New York City, New Yo...Phone Number
(212) 732-4300Website
www.ceocast.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CEOcast
CEOcast produces original and syndicated streaming broadcast interviews of chief executive officers at public and private news-making companies and distributes its programming to millions of online investors at over 700 financial web sites as well as to more than 20,000 portfolio managers, buy-side analysts and traders at more than 3,300 North American institutions. Content is also disseminated to over 7,000 investment research professionals representing over 425 institutions.Explore more
CEOcast Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CEOcast your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
CEOcast, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once CEOcast has new funding data
Check out if CEOcast is spiking on competitors!
Earning: See what the market has to say on CEOcast recently announced quarterly report
Click to see if CEOcast had a recent Job posting/layoffs
Check if CEOcast has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when CEOcast launches new products
Congratulate Masked Content for being promoted to Masked Content at CEOcast
Recommended Actions
Find VP level buyers at CEOcast
Find more new buyers
Company Profile Activity
Activity Insights
CEOcast is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
CEOcast is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about CEOcast.
CEOcast News & Media
Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal 2018 Results Tuesday, October 16, 2018 at 8:30 AM E.T.
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2018 fourth quarter and year end results Tuesday, October 16, 2018, at 8:30 AM E.T. To listen to the conference call dial 1-888-459-5609. International callers can dial 1-973-321-1024. When prompted, use PIN number 6096026. Dial in approximately ten minutes prior to the scheduled teleconference time. A rebroadcast of the call will be available starting approximately two hours after the confereEnzo Biochem to Acquire New Facility for Manufacturing and Distribution to Advance Its Diagnostic and Therapeutic Growth Strategy
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company, announced today that, as part of implementing its growth strategy, it has entered into an agreement to purchase a commercial facility with nearly 36,000 square feet in Farmingdale, NY. The building is adjacent to the Company’s current Long Island campus and enhances the infrastructure needed to produce and distribute Enzo’s expanding low cost, diagnostic platform products and related serPatent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement Case
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) and its subsidiary Enzo Life Sciences, Inc. today announced that the Patent Trial and Appeal Board has denied a petition filed by Hologic, Inc. (NASDAQ:HOLX) for inter partes review, a procedure for challenging the validity of patent claims, against U.S. Patent 6,221,581. Enzo Life Sciences, Inc. is asserting U.S. Patent 6,221,581 in patent infringement litigation against Hologic, Inc., Grifols Diagnostic Solutions, Inc., and Grifols S.A.Enzo Biochem Reports Second Quarter and First Half Results
NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) today announced results for the fiscal quarter and six months ended January 31, 2018. Quarter Highlights (Year over Year) Total revenues for the second fiscal quarter increased to $27.0 million, or 3%, from $26.3 million in the prior year period. Clinical Lab revenues for the quarter totaled $19.5 million, an increase of 4% over the prior year period, despite severe weather impacting operations. Enzo Life Sciences revenue was $7.4
Read more news
Top Broadcasting Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CEOcast
Sign Up For FreeTo access detailed company insights
CEOcast produces original and syndicated streaming broadcast interviews of chief executive officers at public and private news-making companies and distributes its programming to millions of online investors at over 700 financial web sites as well as to more than 20,000 portfolio managers, buy-side analysts and traders at more than 3,300 North Amer... Read More
